Page 88 - ITPS-7-2
P. 88

INNOSC Theranostics and
            Pharmacological Sciences                                     Sujok therapy for patients with respiratory problems



            of dyspnea are obesity,  exercise-induced dyspnea,    Faculty of Medicine, Public Health, and Nursing, Universitas
                                                          6
                                 5
            pregnancy,  and psychological pressure such as anxiety.    Gadjah  Mada-Dr.  Sardjito  General  Hospital,  Yogyakarta,
                                                         3,8
                    7
            Likewise, dyspnea is considered to be the most severe   Indonesia. This study was registered for a clinical study (ID:
            symptom experienced by patients with lung cancer. 9  202103010) in the research repository at Universitas Gadjah
              While it may be difficult to gauge the prevalence of   Mada on March 24, 2021. A research assistant was assigned
            dyspnea, several studies have reported that up to 8.4% of visits   to collect patient data after obtaining patient consent from
            to the emergency department and 2.5% of all doctor visits   all patients before the study.
            require treatment for dyspnea.  In addition, it was reported   2.2. Participants
                                   10
            that about 30% of patients older than 65-years-old had
            difficulty breathing when walking.  Likewise, the prevalence   The participants of this study were selected from two different
                                      11
            of dyspnea is as high as 32% for those over 70 years old. 12  wards: one ward for the CG and the other for the intervention
                                                               group (IG). The inclusion criteria were oxygen saturation <
              Healthcare workers  are responsible  for relieving the   96%, at least one breathing-related symptom (e.g., dyspnea,
            symptoms of dyspnea through comprehensive management   cough, excess sputum production, and chest tightness), and
            of the  disease,  which involves identifying the  cause  of   a grade > 2 on the Likert scale (i.e., 1 – 5; 1 = No symptoms;
                        13
            dyspnea,  treating  it  appropriately, and  optimizing  the   2 = Mild symptoms; 3 = Moderate symptoms; 4 = Severe
            recovery and improvement of dyspnea symptoms. 3    symptoms; and 5 = Very severe symptoms). The exclusion

              Recent research has focused on alternative therapies to   criteria were those who could not respond to the researcher.
            treat dyspnea (e.g., fan therapy, traditional Chinese medicine   Patients from these two wards were approached for
            [TCM], music therapy, hypnosis, yoga, tai-chi, and Qigong),   recruitment based on the inclusion and exclusion criteria,
            but most of these therapies require a long duration, and   and the recruitment process continued until the number
            the corresponding studies lack the utilization of objective   of respondents in each group reached 30. The recruitment
            measurements (e.g., oxygen saturation measurement) to   process was performed by members of the research team
            determine the effect of therapy on dyspnea.        and a lung specialist, and the patients were prospectively
                                                               considered if they had been in these wards for treatment. No
              Nonetheless, the management of dyspnea is often
            overlooked as compared to other potentially severe symptoms   patients were excluded from the recruitment process.
            of respiratory diseases, such as acute and chronic pain, which   2.3. Study procedures
            could be attributed to the patients’ low likelihood of reporting
            the dyspnea symptoms, as well as the complex mechanism of   A Likert scale was used to measure the severity of dyspnea as
                          2
            terminal dyspnea.  In addition, studies often exclude patients   one of the symptoms of respiratory problems. This instrument
            with dyspnea,  and dyspnea is not considered an outcome   was tested with five respondents to determine whether they
                       2
            in  various  interventions.   It  was  also  reported  in  a  study   understood the statement. Subsequently, 52 respondents
                               14
            that the palliative care team in an intensive care unit rarely   were involved in the validity and reliability tests in August
            consulted patients with respiratory problems.  A recent case   2021 (i.e., r = 0.268 and Cronbach’s alpha = 0.65). The Likert
                                               15
            study reported that Sujok therapy could remarkably reduce   scale was then used to collect data from September 2021 to
            dyspnea in patients with COVID-19 within 27  min, and   February 2022 at a hospital in Central Java, Indonesia.
            it warranted further studies with a larger sample size and   During the data collection process, oxygen saturation
            a more rigorous research method to validate its findings.   and symptoms were measured at 0, 5, 15, and 30 min in
            Herein, the present study aimed to evaluate the efficacy of   the CG. In the IG, after oxygen saturation and symptoms
            Sujok therapy to reduce dyspnea symptoms in patients with   were measured at 0 min, the respondents were given Sujok
            an oxygen saturation of <96%.                      therapy,  which  took  approximately  3  min.  Subsequently,
                                                               oxygen saturation and symptoms of respiratory problems
            2. Methods                                         were measured at 5, 15, and 30 min post-therapy. The Sujok
            2.1. Study design                                  therapy was performed as follows: 16
            This quasi-experimental study was conducted with a control   (i)  Massage the areas marked in red and green according
            group (CG) in a hospital in Indonesia. The primary and   to the direction of the arrows (i.e., from inside to
            secondary objectives of this study were to evaluate the effects   the top, from bottom to top, and from outside to the
            of Sujok therapy on the severity of dyspnea in patients and   top) (Figure 1) 30 times with a roller-shaped probe
            on oxygen saturation levels, respectively. This study received   (Figure 2);
            an ethical approval number (KE/FK/0118/EC/2021) from   (ii)  Color areas of the hands according to Figure 1.
            the Medical and Health Research Ethics Committee of the   (iii) Attach fenugreek seeds to the colored areas with tape.


            Volume 7 Issue 2 (2024)                         2                                doi: 10.36922/itps.1418
   83   84   85   86   87   88   89   90   91   92   93